Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 5/20 | 1.00 |
| ▸ | MAOA | P21397 | 4/20 | 0.81 |
| ▸ | HTR2A | P28223 | 2/20 | 0.67 |
| ▸ | GFER | P55789 | 1/20 | 0.62 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.61 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.56 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.56 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.56 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.56 |
| ▸ | NPC1 | O15118 | 1/20 | 0.55 |
| ▸ | RAB9A | P51151 | 1/20 | 0.55 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.53 |
| ▸ | IDO1 | P14902 | 1/20 | 0.52 |
| ▸ | IGF1R | P08069 | 1/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1164263 | 0.98 | MAOB (0.95) | MAOBMAOAHTR2AGFERSIGMAR1 | |
| SCHEMBL10678830 | 0.98 | MAOB (0.95) | MAOBMAOAHTR2AGFERSIGMAR1 | |
| SCHEMBL1164083 | 0.98 | MAOB (0.95) | MAOBMAOAHTR2AGFERSIGMAR1 | |
| SCHEMBL9798973 | 0.95 | MAOB (0.91) | MAOBMAOAHTR2AGFERSIGMAR1 | |
| SCHEMBL4082319 | 0.90 | MAOB (1.00) | MAOBMAOAHTR2AGFERSIGMAR1 | |
| SCHEMBL3111509 | 0.89 | MAOB (0.80) | MAOBMAOAHTR2AGFERSIGMAR1 | |
| Hydrochloric Acid SCHEMBL8746114 | 0.87 | MAOB (1.00) | MAOBMAOAHTR2AGFERSIGMAR1 | |
| SCHEMBL4016540 | 0.87 | MAOB (0.76) | MAOBMAOAHTR2AGFERSIGMAR1 | |
| SCHEMBL12110816 | 0.87 | MAOB (0.76) | MAOBMAOAHTR2AGFERSIGMAR1 | |
| SCHEMBL4022346 | 0.87 | MAOB (0.76) | MAOBMAOAHTR2AGFERSIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120190868-A1 | SUBSTITUTED BENZOCHALCOGENOACENE COMPOUND, THIN FILM COMPRISING THE COMPOUND, AND ORGANIC SEMICONDUCTOR DEVICE INCLUDING THE THIN FILM | NATIONAL UNIVERSITY CORPORATION NAGOYA UNIVERSITY (JP) | 2012-07-26 | — | — | US | disclosed |
| EP-2452942-A1 | SUBSTITUTED BENZOCHALCOGENOACENE COMPOUND, THIN FILM COMPRISING THE COMPOUND, AND ORGANIC SEMICONDUCTOR DEVICE INCLUDING THE THIN FILM | Sumitomo Chemical Company, Limited (JP) | 2012-05-16 | — | — | EP | disclosed |
| US-5015762-A | Alkoxy substituted ureas as herbicides | BASF AKTIENGESELLSCHAFT (DE) | 1991-05-14 | — | — | US | disclosed |
| EP-0041145-B1 | ARALKYL-PHENYL UREAS AND THEIR HERBICIDAL COMPOSITIONS | BASF Aktiengesellschaft (DE) | 1984-12-19 | — | — | EP | disclosed |
| US-4422871-A | Aralkylphenylureas and herbicides containing these | BASF AKTIENGESELLSCHAFT (DE) | 1983-12-27 | — | — | US | disclosed |
| EP-0041145-A2 | Aralkyl-phenyl ureas and their herbicidal compositions | BASF Aktiengesellschaft (DE) | 1981-12-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120190868-A1 | SUBSTITUTED BENZOCHALCOGENOACENE COMPOUND, THIN FILM COMPRISING THE COMPOUND, AND ORGANIC SEMICONDUCTOR DEVICE INCLUDING THE THIN FILM | EBPL, SAAL1, APOL1 | MAOB 1398/4885MAOA 962/4885HTR2A 2932/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.